Skip to main content
2023 NCA TBI Research Symposium Main banner

  • Posters
    57 - Evaluation of hydrogel-mediated drug delivery for mitigation of acute traumatic brain injury neuropathology in rats.
    Primary Presenter: Intisar A. Diwani, BS (she/her/hers) – Walter Reed Army Institute of Research
    Co-Presenter: Linda M. Huynh, BS (she/her/hers) – Walter Reed Army Institute of Research
    Neurotherapeutics
  • Posters
    58 - Role of SUR1 in hemorrhagic progression of contusion in a mouse model of traumatic brain injury
    Primary Presenter: Anandita Gaur, Undergraduate Student (she/her/hers) – Department of Neurosurgery, University of Maryland School of Medicine
    Neurotherapeutics
  • Posters
    59 - Development of Accessible Digitized Tools to Support DoD TBI Clinical Trials Regulatory Compliance
    Primary Presenter: Dominic E. Nathan, MS, PhD – Center for Neuroscience and Regenerative Medicine, HJF
    Neurotherapeutics
  • Posters
    60 - Mobile app selection for Traumatic Brain Injury symptom management and rehabilitation: A framework for clinicians, care givers and patients
    Presenter: Dominic E. Nathan, MS, PhD – Center for Neuroscience and Regenerative Medicine, HJF
    Neurotherapeutics
  • Posters
    61 - Impact of ketone and ketone-ester administration on oxidative stress related to blast-induced traumatic brain injury
    Primary Presenter: Jacob Patterson, BS (he/him/his) – Parsons Corporation/Naval Medical Research Center
    Neurotherapeutics
  • Posters
    62 - Acute 4-aminopyridine (4-AP) Does Not Increase Seizure Risk After Experimental Traumatic Brain Injury With Dosing That Mitigates Axon Damage and Node of Ranvier Disruption
    Primary Presenter: Kryslaine Radomski, PhD (she/her/hers) – USUHS
    Neurotherapeutics
  • Posters
    63 - Randomized, Controlled Clinical Trials of Acoustic and Electrical Scalp Stimulation Neurotechnology to Reduce Postconcussive Symptoms after Mild Traumatic Brain Injury
    Presenter: Michael J. Roy, MPH, MD (he/him/his) – Center for Neuroscience and Regenerative Medicine, USU
    Neurotherapeutics
  • Posters
    64 - Can A Cognitive-Behavioral Therapy Digital Therapeutic App Combat Symptoms of Depression in Service Members and Veterans with Mild Traumatic Brain Injury? A Methodological Approach.
    Primary Presenter: Olivia Shaw, BS (she/her/hers) – Center for Neuroscience and Regenerative Medicine, HJF
    Co-Presenter: Noushin Mannan, BS (she/her/hers) – Center for Neuroscience and Regenerative Medicine, HJF
    Neurotherapeutics
  • Posters
    65 - Effects of a Subanesthetic Ketamine Infusion on Inflammatory and Behavioral Outcomes after Closed Head Injury in Rats
    Primary Presenter: Haley Spencer, Graduate Student – Uniformed Services University
    Neurotherapeutics
  • Posters
    66 - Proof-of-concept evaluation of intravenous anti-CD47 antibodies for augmentation of hematoma clearance and mitigation of acute neuropathology in a rat model of penetrating traumatic brain injury
    Presenter: Ping Wang, PhD (she/her/hers) – Walter Reed Army Institute of Research
    Neurotherapeutics
  • Posters
    67 - Inhibition of 2-AG degradation ameliorates post-traumatic headache associated with mild traumatic brain injury
    Primary Presenter: Jie Wen, PhD (she/her/hers) – department of Anatomy, Physiology and Genetics USUHS
    Neurotherapeutics
  • Friday, Mar 10th
    2:15 PM – 3:15 PM East Coast USA Time
    Neurotherapeutics
    Location: Orem Alumni Hall Section 2
    *Moderator: Susanna Scafidi, MD – Johns Hopkins University School of Medicine
    Neurotherapeutics
  • Friday, Mar 10th
    2:15 PM – 2:35 PM East Coast USA Time
    Acetate-based Energy Supplements Preserved Mitochondrial Bioenergetic Responses After Penetrating Traumatic Brain Injury
    Location: Orem Alumni Hall Section 2
    Presenter: Jignesh Pandya, PhD (he/him/his) – Brain Trauma Neuroprotection Branch, Walter Reed Army Institute of Research
    Neurotherapeutics
  • Friday, Mar 10th
    2:35 PM – 2:55 PM East Coast USA Time
    Pharmacological manipulations of axonal NAD+ metabolism prevent Wallerian degeneration in injured axons
    Location: Orem Alumni Hall Section 2
    Neurotherapeutics
  • Friday, Mar 10th
    2:55 PM – 3:15 PM East Coast USA Time
    Novel soluble TNF inhibitor improves outcomes in a mouse model of traumatic brain injury-induced AD
    Location: Orem Alumni Hall Section 2
    Presenter: Michelle Taylor, Graduate Student (she/her/hers) – Virginia Commonwealth University
    Neurotherapeutics